Clinical Benefits of a Blood Glucose Monitoring System in Patients With Type 2 Diabetes

Inclusion Criteria:· * Current diagnosis of type 2 diabetes * Diagnosed at least 3 months prior to the start of the study but not more than 15 years from the start of the study * Stable regimen (i.e., no changes in therapeutic regimen) for the past three months * Baseline HbA1c of 7.0 to 8.9%, inclusive Exclusion Criteria: * Using insulin * Using oral agents that target post-prandial hyperglycemia (Note: These medications may be added during the study) * Known history of anemia or disorders associated with anemia * Has previously used the devices being tested in the study